MCM
NVO

Monarch Capital Management’s Novo Nordisk NVO Stock Holding History

Monarch Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Buy
16,150
+1,865
+13% +$80.1K 0.18% 86
2026
Q1 		$536K Buy
14,285
+4,381
+44% +$208K 0.13% 97
2025
Q4 		$504K Buy
9,904
+5,684
+135% +$291K 0.12% 95
2025
Q3 		$234K Buy
+4,220
New +$247K 0.06% 116

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Monarch Capital Management's NVO Position: Q2 2026 in Review

Monarch Capital Management increased its Novo Nordisk (NVO) stake by 13% in Q2 2026, buying an estimated $80.1K and bringing the position to 16,150 shares worth $774K. The position accounts for 0.18% of the portfolio, ranked #86.

Monarch Capital Management first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Monarch Capital Management held 16,150 shares of Novo Nordisk worth $774K as of Q2 2026.
  • Monarch Capital Management bought 1,865 Novo Nordisk shares in Q2 2026, an estimated $80.1K.
  • Novo Nordisk made up 0.18% of Monarch Capital Management's portfolio in Q2 2026, its #86 holding.
  • Monarch Capital Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.